Physician profile
Stephanie M Wright
NPI 1902873524
$978.70
in general payments reported to CMS, 2019-2025
16 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.10 · 2022: $211 · 2023: $267 · 2024: $271 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.40 | 2021-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Regeneron Healthcare Solutions, INC. | $165.11 | 2023-2024 | Dupixent |
| Mayne Pharma Commercial LLC | $86.55 | 2025 | |
| Organon LLC | $52.35 | 2023-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $41.63 | 2021-2022 | |
| Exeltis, USA INC. | $28.64 | 2024-2025 | Slynd |
| Agile Therapeutics, INC. | $27.45 | 2021-2023 | Twirla |
| Genzyme Corporation | $27.03 | 2024 | |
| Medtronic, INC. | $23.22 | 2024 | Ligasure |
| Qol Medical, LLC | $22.65 | 2023 | Sucraid |
| Albireo Pharma, INC. | $22.05 | 2023 | Bylvay |
| Pharming Healthcare, INC. | $20.05 | 2022 | |
| Travere Therapeutics, INC. | $18.61 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.75 | 2022 | |
| Sandoz INC. | $13.08 | 2024 | Hyrimoz |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.